General description
Poids réel (observé) : env. 165 kDa. Target bands appear larger than the calculated molecular weights of 131.4/129.7 kDa (human NKCC1 isoform 1/2), 121.5/121.4 kDa (human NKCC2 isoform A/F), 131.0 kDa (mouse NKCC1), 120.4/120.3/120.3 kDa (mouse NKCC2 isoform A/B/F), and 130.4/120.6 kDa (rat NKCC1/NKCC2) due to glycosylation. Des bandes non caractérisées peuvent être observées avec certains lysats.
Solute carrier family 12 member 1 (UniProt Q13621; a.k.a. Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 2) and solute carrier family 12 member 2 (UniProt P55011; a.k.a. Basolateral Na-K-Cl symporter, Bumetanide-sensitive sodium-(potassium)-chloride cotransporter 1) are encoded by the SLC12A1 (a.k.a. NKCC2; Gene ID 6557) and SLC12A2 (a.k.a. NKCC1; Gene ID 6558) gene, respectively, in human. NKCC1 (SLC12A2) and NKCC2 (SLC12A1) belong to the subfamily of cation-chloride cotransporters (CCCs) that mediate electroneutral transport of sodium, potassium and chloride across the plasma membrane and are inhibited by bumetanide and furosemide-type of compounds. NKCCs play an important role in cell volume regulation, where NKCC2 is involved in reabsorption of salt and osmotically-obliged water in renal epithelial cells, while NKCC1 has a major impact on intracellular chloride ion concentration ([Cl-]i) in vascular smooth muscle cells (VSMCs) and neuronal cells. In primary hypertension, NKCC1 activity is increased in VSMCs and paraventricular nucleus (PVN) neurons, leading to elevated peripheral resistance in systemic circulation and activation of sympathetic nerve system (SNS), respectively. Human NKCC1 and NKCC2 are 12-transmembrane proteins having their N- and C-terminal ends exposed at the cytoplasmic side (a.a. 1-285 and 921-1212 of NKCC1; a.a. 1-177 and 814-1099 of NKCC2).
Immunogen
Recombinant human NKCC1 C-terminal fragment.
Application
&
Domaine de recherche
Signalisation
Biochem/physiol Actions
Clone T4 recognizes both NKCC1 and NKCC2 by targeting a C-terminal region epitope exposed only under denaturing condition, and unaccessible for antibody binding when NKCC assumes its native conformation (Lytle, C., et al. (1995). Am. J. Physiol. 269(6 Pt 1):C1469-C1505).
Physical form
κ
Format : Produit purifié
Produit purifié sur protéine G.
Preparation Note
Stable entre 2 et 8 °C pendant 1 an à compter de la date de réception.
Analysis Note
Produit évalué par western blotting sur des lysats de cellules HeLa.
Analyse par western blotting : µµ
Other Notes
Concentration : Voir la fiche technique du lot concerné.
Disclaimer
Sauf indication contraire dans notre catalogue ou toute autre documentation associée au(x) produit(s), nos produits sont uniquement destinés à la recherche et ne sauraient être utilisés à d'autres fins, ce qui inclut, sans s'y limiter, les utilisations commerciales non autorisées, les utilisations diagnostiques in vitro, les utilisations thérapeutiques ex vivo ou in vivo, ou tout type de consommation ou d'application chez l'être humain ou chez l'animal.